The effects of somatostatin (SRIF), insulin, and triiodothyronine (T3) on 
Introduction
Liver is a good model for the study of growth control of mammalian cells since it has a strong ability to regenerate and responds to many hormones. In vitro studies indicate that hormones and growth factors such as glucagon, insulin, epidermal growth factor, etc., can stimulate the DNA synthesis of rat hepatocytes (reviewed in ref. 1) . However, normal adult rat liver cells do not divide frequently in vivo. The estimated spontaneous proliferation rate ofadult rat hepatocytes lies only in the range of0.05% to 0.005% (2) . The proliferation of normal hepatocytes may be regulated by the interactions ofthe cell with both growth factors and growth inhibitors. The growth inhibitor of normal human hepatocytes has not yet been identified. Somatostatin (SRIF),' a cyclic 14-amino acid peptide, was originally discovered as a hypothalamic inhibitor of pituitary growth hormone secretion (3) . Recently, SRIF was also found in the pancreatic islets and throughout the gastrointestinal tract.
SRIF has been postulated to regulate the nutrient homeostasis by affecting gastrointestinal function and nutrient absorption (4, 5) . In the present study, a well-differentiated human hepatoma cell line-Hep3B (6) Serum starvation of human hepatoma cells. Cells from confluent stock plates were trypsinized and plated into 24-well cell culture plates at a density of 1 X 10' cells per well in DME with 10% FCS and were allowed to attach overnight. Cells were then washed three times with Hanks' balanced salt solution with Ca2, Mg2+, pH 7.0 and the medium was changed to DME without serum every 2 d for a total of 6 d. Cells stopped dividing at the end of serum starvation.
Radioimmunoassay ofSRIF. SRIF in the culture medium was determined by radioimmunoassay essentially as described previously (7).
In brief, "'I-Tyr-SRIF was used as the tracer, together with a highly specific rabbit anti-SRIF serum (final dilution 1:100,000). Samples were incubated with the antisera, 1251I-Tyr-SRIF (8, 000 cpmr) and the assay buffer (50 mM ammonium acetate, 150 mM NaCl, 50 mM EDTA and 0.5% bovine serum albumin) at 4VC for 48 h. Separation of the free and bound form of SRIF was done by using 0.3% dextran-coated charcoal.
The limit of detection using these assay conditions was 50 pg ml-'. The recovery of SRIF in culture media at zero time was -98±5%.
Insulin binding assay. The I"'-labeled insulin was iodinated by the chloroamine-T method with a specific activity of 150 ;zCi/lg (8 10 ,Ci/nmol).
The reaction was continued for I min at 370C and stopped by adding SDS sample buffer to make a final concentration of 1% SDS, 0.2 M mercaptoethanol, 10% glycerol. Samples were boiled at 100IC for 3 min and subjected to SDS-polyacrylamide gel electrophoresis.
Gel electrophoresis and autoradiography. Samples were run on 10% polyacrylamide slab gel in the presence of0.1% SDS, using the procedure of Laemmli (10) . After staining with Coomassie Brilliant Blue, and destaining, the gels were dried and subjected to autoradiography at -70'C using Fuji x-ray film.
Results
After the cell growth was arrested by 6 d serum starvation, human hepatoma Hep3B cells were continuously cultured in DME alone or with various amounts of porcine insulin, T3 and SRIF added. As shown in Fig. 1 , the insulin and T3 induced a dosedependent stimulation ofcell proliferation of Hep3B cells. SRIF exerted only a little, but significant, growth-promoting activity. For both insulin and T3, the minimal effective concentration to stimulate the growth ofserum-starved Hep3B cells was about 10-10 M. When SRIF was added simultaneously with insulin and T3, only the growth-promoting activity of insulin was inhibited (Fig. 2) . The inhibitory effect of SRIF towards insulininduced cell growth was dose dependent. Similar observation was made on FCS; that is the proliferation of serum-starved HORMONE log (M) Figure 1 . Effect of T3, insulin, and SRIF on cell growth of serumstarved human hepatoma cells Hep3B. Cells were plated into 24-well cell culture plates at a density of 1 X 10 cells per well and serum starved as described in Methods. After a 64 serum starvation, the medium was changed to DME alone or various amounts of porcine insulin, T3, and SRIF were added. Hep3B cells induced by 10% fetal calf serum was also inhibited by SRIF (Fig. 2) . On the other hand, the growth-promoting activity of T3 was not inhibited by SRIF at all.
Since the inhibitory effect of SRIF was observed after 2 d incubation, the disappearance rate of SRIF under our culture condition was thus determined. Radioimmunoassay using a specific antiserum against SRIF was performed to determine the amount of SRIF remaining in the cultured media. respectively, and then stored at -70'C before assay. Radioimmunoassay of SRIF in the culture medium was performed as described in Methods.
this hypothesis, insulin binding on Hep3B cells was determined in the presence of SRIF. Specific binding of labeled insulin on monolayered Hep3B cells was observed (Fig. 4) The protein kinase activity of the partially purified insulin receptors was also examined. Insulin stimulates the autophosphorylation of the (3-subunit of the insulin receptor of Hep3B in vitro with half-maximal concentration of 5 mM. SRIF, at a concentration of 2 gg ml-', shows no significant effect on the insulin-dependent autophosphorylation of ,8-subunits of the insulin receptor (Fig. 4, inset) .
Discussion
The growth promoting activity of insulin and T3 has been demonstrated in cultured rat hepatocytes (12, 13) , but not reported for human liver cells (12, 13) . The present study showed that insulin and T3 also stimulate serum starved human hepatoma cells Hep3B to proliferate in a chemically defined media. The dose response of insulin-stimulated cell growth in Hep3B cells occurs over a wide range of concentration (from 0.1 nM to 1 ,MM). At low concentration (1 nM), insulin is likely to act through the high affinity insulin receptor with Kd of0.5 nM. On the other hand, the mitogenic activity of insulin at high concentration The concentration of SRIF needed to inhibit the growthpromoting activity of insulin on Hep3B cells was about 10 ng ml-', which is 10 to 100 times higher than the concentration of SRIF in the circulation (17, 18) . Such a discrepancy may be attributed to the labile nature of SRIF during these particular experimental conditions. Recently, it was estimated that the halflife of infused SRIF in the plasma of normal human subjects is only -2 min (7). However, SRIF has also been identified in pancreas (18) Since both insulin and SRIF act through their own specific receptors on the cell surface (23), the selective inhibition ofinsulin but not T3-induced cell proliferation by SRIF may result from the interference of the membrane-bound signal transduction systems ofhormones (24) . It has been reported that SRIF inhibits multi receptor-mediated adenylate cyclase activity through the inhibitory guanine nucleotide binding protein (25) . However, no change of intracellular cAMP level of Hep3B cells was observed during SRIF treatment, indicating that some cAMP-independent events may be involved in SRIF actions (unpublished observations). The finding that SRIF did not prevent insulin from binding to its surface receptors nor inhibit the kinase activity of purified insulin receptors raises an interesting question about the mechanism of SRIF actions. Whether SRIF acts through its own receptor to interfere with insulin receptor kinase activity in vivo or to prevent insulin induced Ca2' flux is not clear at present but is currently under investigation.
